Toong-Hua LIANG et al. 2020. Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial. Archives of Rheumatology. 35, 2 (Jun. 2020), 170–179. DOI:https://doi.org/10.46497/ArchRheumatol.2020.7464.